investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
The role of IWS1 in development and tumorigenesis
Philip N Tsichlis
7 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Nathanael S Gray
Developing Selective EphA2 Inhibitors for the Treatment of Cancer
Breast
Melanoma of skin
Trachea, bronchus and lung
Andrew Andrew Futreal
Role of Tumor Stroma in Therapeutic Response and Resistance
Melanoma of skin
Pathology
Stanley Lipkowitz
TRAIL-induced Cell Death in Breast Cancer Cells
Breast
Zhiyuan Shen
Alternative Mechanisms to Inactivate p53 during Oncogenesis
Breast
Antony Gakwaya
What are the Possible Genetic Risk Factors of Breast Cancer in Black African Women?
Breast
Brian K. Kobilka
Beta2 Adrenoceptor Structure and Mechanism of Activation
Melanoma of skin
Brian D Dynlacht
Targeted Screen for Novel Chemical Modulators of Wnt/Beta-Cat Signaling Pathway.
Breast
Collin Melton
Identification, Characterization, and Prediction of Cancer Driver Mutations in Regulatory Regions
Melanoma of skin
John Koren
Novel Combination Therapeutic Strategies to Ablate Resistance to Hsp90 Inhibitors
Melanoma of skin